Département de Chimie Moléculaire

A biosensor device is defined by its biological, or bioinspired receptor unit with unique specificities toward corresponding analytes. These analytes are often of biological origin like DNAs of bacteria or viruses, or proteins which are generated from the immune system (antibodies, antigens) of infected or contaminated living organisms. Such analytes can also be simple molecules like glucose or pollutants when a biological receptor unit with particular specificity is available. One of many other challenges in biosensor development is the efficient signal capture of the biological recognition event (transduction). Such transducers translate the interaction of the analyte with the biological element into electrochemical, electrochemiluminescent, magnetic, gravimetric, or optical signals. In order to increase sensitivities and to lower detection limits down to even individual molecules, nanomaterials are promising candidates due to the possibility to immobilize an enhanced quantity of bioreceptor units at reduced volumes and even to act itself as transduction element. Among such nanomaterials, gold nanoparticles, semi-conductor quantum dots, polymer nanoparticles, carbon nanotubes, nanodiamonds, and graphene are intensively studied. Due to the vast evolution of this research field, this review summarizes in a non-exhaustive way the advantages of nanomaterials by focusing on nano-objects which provide further beneficial properties than "just" an enhanced surface area.

The lithium/sulfur battery is a promising electrochemical system that has a high theoretical capacity of 1675 mAh g(-1), but its discharge mechanism is well-known to be a complex multistep process. As the active material dissolves during cycling, this discharge mechanism was investigated through the electrolyte characterization. Using high-performance liquid chromatography, UV-visible absorption, and electron spin resonance spectroscopies, we investigated the electrolyte composition at different discharge potentials in a TEGDME-based electrolyte. In this study, we propose a possible mechanism for sulfur reduction consisting of three steps. Long polysulfide chains are produced during the first reduction step (2.4-2.2 V vs Li(+)/Li), such as S(8)(2-) and S(6)(2-), as evidenced by UV and HPLC data. The S(3)(•-) radical can also be found in solution because of a disproportionation reaction. S(4)(2-) is produced during the second reduction step (2.15-2.1 V vs Li(+)/Li), thus pointing out the gradual decrease of the polysulfide chain lengths. Finally, short polysulfide species, such as S(3)(2-), S(2)(2-), and S(2-), are produced at the end of the reduction process, i.e., between 2.1 and 1.9 V vs Li(+)/Li. The precipitation of the poorly soluble and insulating short polysulfide compounds was evidenced, thus leading to the positive electrode passivation and explaining the early end of discharge.

The classic density-functional theory (DFT) formalism introduced by Hohenberg, Kohn, and Sham in the mid-1960s is based on the idea that the complicated N-electron wave function can be replaced with the mathematically simpler 1-electron charge density in electronic structure calculations of the ground stationary state. As such, ordinary DFT cannot treat time-dependent (TD) problems nor describe excited electronic states. In 1984, Runge and Gross proved a theorem making TD-DFT formally exact. Information about electronic excited states may be obtained from this theory through the linear response (LR) theory formalism. Beginning in the mid-1990s, LR-TD-DFT became increasingly popular for calculating absorption and other spectra of medium- and large-sized molecules. Its ease of use and relatively good accuracy has now brought LR-TD-DFT to the forefront for this type of application. As the number and the diversity of applications of TD-DFT have grown, so too has our understanding of the strengths and weaknesses of the approximate functionals commonly used for TD-DFT. The objective of this article is to continue where a previous review of TD-DFT in Volume 55 of the Annual Review of Physical Chemistry left off and highlight some of the problems and solutions from the point of view of applied physical chemistry. Because doubly-excited states have a particularly important role to play in bond dissociation and formation in both thermal and photochemistry, particular emphasis is placed on the problem of going beyond or around the TD-DFT adiabatic approximation, which limits TD-DFT calculations to nominally singly-excited states.

Enzymatic fuel cells use enzymes to produce energy from bioavailable substrates. However, such biofuel cells are limited by the difficult electrical wiring of enzymes to the electrode. Here we show the efficient wiring of enzymes in a conductive pure carbon nanotube matrix for the fabrication of a glucose biofuel cell (GBFC). Glucose oxidase and laccase were respectively incorporated in carbon nanotube disks by mechanical compression. The characterization of each bioelectrode shows an open circuit potential corresponding to the redox potential of the respective enzymes, and high current densities for glucose oxidation and oxygen reduction. The mediatorless GBFC delivers a high power density up to 1.3 mW cm−2 and an open circuit voltage of 0.95 V. Moreover, the GBFC remains stable for 1 month and delivers 1 mW cm−2 power density under physiological conditions (5×10−3 mol l−1 glucose, pH 7). To date, these values are the best performances obtained for a GBFC. Glucose biofuel cells can be used to produce clean energy from renewable sources, but their use is limited by poor stability and low power output. In this study, bioelectrodes are fabricated using carbon nanotubes and the resulting biofuel cells have improved stability and power.

Manganese at work: Carbonyl bipyridyl complexes based on manganese, a non-noble abundant and inexpensive metal, have been proved to be excellent molecular catalysts for the selective electrochemical reduction of CO2 to CO under mild conditions. Another advantage of manganese complexes over rhenium complexes is that these catalysts operate at markedly less overpotential (0.40 V gain). Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

The changes in gene expression underlying the yeast adaptive stress response to H2O2 were analyzed by comparative two-dimensional gel electrophoresis of total cell proteins. The synthesis of at least 115 proteins is stimulated by H2O2, whereas 52 other proteins are repressed by this treatment. We have identified 71 of the stimulated and 44 of the repressed targets. The kinetics and dose-response parameters of the H2O2 genomic response were also analyzed. Identification of these proteins and their mapping into specific cellular processes give a distinct picture of the way in which yeast cells adapt to oxidative stress. As expected, H2O2-responsive targets include an important number of heat shock proteins and proteins with reactive oxygen intermediate scavenging activities. Exposure to H2O2 also results in a slowdown of protein biosynthetic processes and a stimulation of protein degradation pathways. Finally, the most remarkable result inferred from this study is the resetting of carbohydrate metabolism minutes after the exposure to H2O2. Carbohydrate fluxes are redirected to the regeneration of NADPH at the expense of glycolysis. This study represents the first genome-wide characterization of a H2O2-inducible stimulon in a eukaryote.

This review article presents the most recent developments in the use of materials based on dipyrromethene (DPM) and azadipyrromethenes (ADPM) for organic photovoltaic (OPV) applications. These chromophores and their corresponding BF2-chelated derivatives BODIPY and aza-BODIPY, respectively, are well known for fluorescence-based applications but are relatively new in the field of photovoltaic research. This review examines the variety of relevant designs, synthetic methodologies and photophysical studies related to materials that incorporate these porphyrinoid-related dyes in their architecture. The main idea is to inspire readers to explore new avenues in the design of next generation small-molecule and bulk-heterojunction solar cell (BHJSC) OPV materials based on DPM chromophores. The main concepts are briefly explained, along with the main challenges that are to be resolved in order to take full advantage of solar energy.

Multivalency plays a major role in biological processes and particularly in the relationship between pathogenic microorganisms and their host that involves protein-glycan recognition. These interactions occur during the first steps of infection, for specific recognition between host and bacteria, but also at different stages of the immune response. The search for high-affinity ligands for studying such interactions involves the combination of carbohydrate head groups with different scaffolds and linkers generating multivalent glycocompounds with controlled spatial and topology parameters. By interfering with pathogen adhesion, such glycocompounds including glycopolymers, glycoclusters, glycodendrimers and glyconanoparticles have the potential to improve or replace antibiotic treatments that are now subverted by resistance. Multivalent glycoconjugates have also been used for stimulating the innate and adaptive immune systems, for example with carbohydrate-based vaccines. Bacteria present on their surfaces natural multivalent glycoconjugates such as lipopolysaccharides and S-layers that can also be exploited or targeted in anti-infectious strategies.

We report modification of graphene oxide by thermal reduction to obtain reduced graphene oxide and subsequent functionalization with sulfophenyl groups to obtain SRGO as well as the characterization of these materials by TGA-MS.

The ever-increasing demands for clean and sustainable energy sources combined with rapid advances in biointegrated portable or implantable electronic devices have stimulated intensive research activities in enzymatic (bio)fuel cells (EFCs). The use of renewable biocatalysts, the utilization of abundant green, safe, and high energy density fuels, together with the capability of working at modest and biocompatible conditions make EFCs promising as next generation alternative power sources. However, the main challenges (low energy density, relatively low power density, poor operational stability, and limited voltage output) hinder future applications of EFCs. This review aims at exploring the underlying mechanism of EFCs and providing possible practical strategies, methodologies and insights to tackle these issues. First, this review summarizes approaches in achieving high energy densities in EFCs, particularly, employing enzyme cascades for the deep/complete oxidation of fuels. Second, strategies for increasing power densities in EFCs, including increasing enzyme activities, facilitating electron transfers, employing nanomaterials, and designing more efficient enzyme-electrode interfaces, are described. The potential of EFCs/(super)capacitor combination is discussed. Third, the review evaluates a range of strategies for improving the stability of EFCs, including the use of different enzyme immobilization approaches, tuning enzyme properties, designing protective matrixes, and using microbial surface displaying enzymes. Fourth, approaches for the improvement of the cell voltage of EFCs are highlighted. Finally, future developments and a prospective on EFCs are envisioned.

In this review, we discuss the use of binary and multi-component metal oxides as independent electrocatalysts, co-catalysts and supports for various anode oxidation and cathode reduction reactions in polymer electrolyte fuel cells.

Autophagy has emerged as a critical lysosomal pathway that maintains cell function and survival through the degradation of cellular components such as organelles and proteins. Investigations specifically employing the liver or hepatocytes as experimental models have contributed significantly to our current knowledge of autophagic regulation and function. The diverse cellular functions of autophagy, along with unique features of the liver and its principal cell type the hepatocyte, suggest that the liver is highly dependent on autophagy for both normal function and to prevent the development of disease states. However, instances have also been identified in which autophagy promotes pathological changes such as the development of hepatic fibrosis. Considerable evidence has accumulated that alterations in autophagy are an underlying mechanism of a number of common hepatic diseases including toxin-, drug- and ischemia/reperfusion-induced liver injury, fatty liver, viral hepatitis and hepatocellular carcinoma. This review summarizes recent advances in understanding the roles that autophagy plays in normal hepatic physiology and pathophysiology with the intent of furthering the development of autophagy-based therapies for human liver diseases.

A general formalism is presented to calculate the neutron incoherent scattering law for diffusion in a potential of spherical symmetry and applied to the problem of diffusion of a particle in the interior of a sphere with an impermeable surface. The shape of the spectra and their behaviour versus the momentum transfer predicted by this model is discussed and compared to those of simpler models. This model should satisfactorily describe molecular diffusion in restricted geometries in three dimensions, e.g. water molecules around hydrophilic centres in solids.

Powering future generations of implanted medical devices will require cumbersome transcutaneous energy transfer or harvesting energy from the human body. No functional solution that harvests power from the body is currently available, despite attempts to use the Seebeck thermoelectric effect, vibrations or body movements. Glucose fuel cells appear more promising, since they produce electrical energy from glucose and dioxygen, two substrates present in physiological fluids. The most powerful ones, Glucose BioFuel Cells (GBFCs), are based on enzymes electrically wired by redox mediators. However, GBFCs cannot be implanted in animals, mainly because the enzymes they rely on either require low pH or are inhibited by chloride or urate anions, present in the Extra Cellular Fluid (ECF). Here we present the first functional implantable GBFC, working in the retroperitoneal space of freely moving rats. The breakthrough relies on the design of a new family of GBFCs, characterized by an innovative and simple mechanical confinement of various enzymes and redox mediators: enzymes are no longer covalently bound to the surface of the electron collectors, which enables use of a wide variety of enzymes and redox mediators, augments the quantity of active enzymes, and simplifies GBFC construction. Our most efficient GBFC was based on composite graphite discs containing glucose oxidase and ubiquinone at the anode, polyphenol oxidase (PPO) and quinone at the cathode. PPO reduces dioxygen into water, at pH 7 and in the presence of chloride ions and urates at physiological concentrations. This GBFC, with electrodes of 0.133 mL, produced a peak specific power of 24.4 microW mL(-1), which is better than pacemakers' requirements and paves the way for the development of a new generation of implantable artificial organs, covering a wide range of medical applications.

The human serum immunoglobulins IgG and IgA1 are produced in bone marrow and both interact with specific cellular receptors that mediate biological events. In contrast to IgA1, the glycosylation of IgG has been well characterized, and its interaction with various Fc receptors (Fc Rs) has been well studied. In this paper, we have analyzed the glycosylation of IgA1 and IgA1 Fab and Fc as well as three recombinant IgA1 molecules, including two N-glycosylation mutants. Amino acid sequencing data of the IgA1 Fc O-glycosylated hinge region indicated that O-glycans are located at Thr228, Ser230, and Ser232, while O-glycan sites at Thr225 and Thr236 are partially occupied. Over 90% of the N-glycans in IgA1 were sialylated, in contrast to IgG, where < 10% contain sialic acid. This paper contains the first report of Fab glycosylation in IgA1, and (in contrast to IgG Fab, which contains only N-linked glycans) both N- and O-linked oligosaccharides were identified. Analysis of the N-glycans attached to recombinant IgA1 indicated that the Cα 2 N-glycosylation site contained mostly biantennary glycans, while the tailpiece site, absent in IgG, contained mostly triantennary structures. Further analysis of these data suggested that processing at one Fc N-glycosylation site affects the other. Neutrophil Fcα R binding studies, using recombinant IgA1, indicated that neither the tailpiece region nor the N-glycans in the C alpha 2 domain contribute to IgA1-neutrophil Fcα R binding. This contrasts with IgG, where removal of the Fc N-glycans reduces binding to the Fcγ R. The primary sequence and disulfide bond pattern of IgA1, together with the crystal structures of IgG1 Fc and mouse IgA Fab and the glycan sequencing data, were used to generate a molecular model of IgA1. As a consequence of both the primary sequence and S-S bond pattern, the N-glycans in IgA1 Fc are not confined within the inter-α-chain space. The accessibility of the Cα 2 N-glycans provides an explanation for the increased sialylation and galactosylation of IgA1 Fc over that of IgG Fc N-glycans, which are confined in the space between the two Cγ 2 domains. This also suggests why in contrast to IgG Fc, the IgA1 N-glycans are not undergalactosylated in rheumatoid arthritis.

Water autoionization reaction 2H2O --> H3O- + OH- is a textbook process of basic importance, resulting in pH = 7 for pure water. However, pH of pure water surface is shown to be significantly lower, the reduction being caused by proton stabilization at the surface. The evidence presented here includes ab initio and classical molecular dynamics simulations of water slabs with solvated H3O+ and OH- ions, density functional studies of (H2O)(48)H+ clusters, and spectroscopic isotopic-exchange data for D2O substitutional impurities at the surface and in the interior of ice nanocrystals. Because H3O+ does, but OH- does not, display preference for surface sites, the H2O surface is predicted to be acidic with pH < 4.8. For similar reasons, the strength of some weak acids, such as carbonic acid, is expected to increase at the surface. Enhanced surface acidity can have a significant impact on aqueous surface chemistry, e.g., in the atmosphere.

We describe the first implanted glucose biofuel cell (GBFC) that is capable of generating sufficient power from a mammal's body fluids to act as the sole power source for electronic devices. This GBFC is based on carbon nanotube/enzyme electrodes, which utilize glucose oxidase for glucose oxidation and laccase for dioxygen reduction. The GBFC, implanted in the abdominal cavity of a rat, produces an average open-circuit voltage of 0.57 V. This implanted GBFC delivered a power output of 38.7 μW, which corresponded to a power density of 193.5 μW cm(-2) and a volumetric power of 161 μW mL(-1). We demonstrate that one single implanted enzymatic GBFC can power a light-emitting diode (LED), or a digital thermometer. In addition, no signs of rejection or inflammation were observed after 110 days implantation in the rat.

BACKGROUND: Male infertility affects >20 million men worldwide and represents a major health concern. Although multifactorial, male infertility has a strong genetic basis which has so far not been extensively studied. Recent studies of consanguineous families and of small cohorts of phenotypically homogeneous patients have however allowed the identification of a number of autosomal recessive causes of teratozoospermia. Homozygous mutations of aurora kinase C (AURKC) were first described to be responsible for most cases of macrozoospermia. Other genes defects have later been identified in spermatogenesis associated 16 (SPATA16) and dpy-19-like 2 (DPY19L2) in patients with globozoospermia and more recently in dynein, axonemal, heavy chain 1 (DNAH1) in a heterogeneous group of patients presenting with flagellar abnormalities previously described as dysplasia of the fibrous sheath or short/stump tail syndromes, which we propose to call multiple morphological abnormalities of the flagella (MMAF). METHODS: A comprehensive review of the scientific literature available in PubMed/Medline was conducted for studies on human genetics, experimental models and physiopathology related to teratozoospermia in particular globozoospermia, large headed spermatozoa and flagellar abnormalities. The search included all articles with an English abstract available online before September 2014. RESULTS: Molecular studies of numerous unrelated patients with globozoospermia and large-headed spermatozoa confirmed that mutations in DPY19L2 and AURKC are mainly responsible for their respective pathological phenotype. In globozoospermia, the deletion of the totality of the DPY19L2 gene represents ∼ 81% of the pathological alleles but point mutations affecting the protein function have also been described. In macrozoospermia only two recurrent mutations were identified in AURKC, accounting for almost all the pathological alleles, raising the possibility of a putative positive selection of heterozygous individuals. The recent identification of DNAH1 mutations in a proportion of patients with MMAF is promising but emphasizes that this phenotype is genetically heterogeneous. Moreover, the identification of mutations in a dynein strengthens the emerging point of view that MMAF may be a phenotypic variation of the classical forms of primary ciliary dyskinesia. Based on data from human and animal models, the MMAF phenotype seems to be favored by defects directly or indirectly affecting the central pair of axonemal microtubules of the sperm flagella. CONCLUSIONS: The studies described here provide valuable information regarding the genetic and molecular defects causing infertility, to improve our understanding of the physiopathology of teratozoospermia while giving a detailed characterization of specific features of spermatogenesis. Furthermore, these findings have a significant influence on the diagnostic strategy for teratozoospermic patients allowing the clinician to provide the patient with informed genetic counseling, to adopt the best course of treatment and to develop personalized medicine directly targeting the defective gene products.

A novel, inexpensive, and simple amperometric biosensor based on immobilization of polyphenol oxidase (PPO) into Zn-Al layered double hydroxides, also called anionic clays, is applied for determination of cyanide. The detection of cyanide was performed via its inhibiting action on the PPO electrode. Measurement was carried out with 3,4-dihydroxyphenylacetic acid as enzyme substrate, the enzymatically generated quinoid products being electroreduced at -0.2 V. An extremely sensitive detection limit (0.1 nM) was obtained for cyanide. Enzyme immobilization into an anionic exchanger clay seems to cause an increase in cyanide inhibition effects because of anion accumulation in the clay matrix.

European Journal of BiochemistryVolume 179, Issue 2 p. 255-266 Free Access Molecular mechanism of visual transduction Marc CHABRE, Corresponding Author Marc CHABRE Laboratoire de Biophysique Moléculaire et Cellulaire (Unité Associée 520 au CNRS), Département Recherche Fondamentale, Centre ďÉtudes Nucléaires, GrenobleCorrespondence to M. Chabre, Laboratoire de Biophysique Moléculaire et Cellulaire. CENG Boîte Postale 85X, F-38041 Grenoble, FranceSearch for more papers by this authorPhilippe DETERRE, Philippe DETERRE Laboratoire de Biophysique Moléculaire et Cellulaire (Unité Associée 520 au CNRS), Département Recherche Fondamentale, Centre ďÉtudes Nucléaires, GrenobleSearch for more papers by this author Marc CHABRE, Corresponding Author Marc CHABRE Laboratoire de Biophysique Moléculaire et Cellulaire (Unité Associée 520 au CNRS), Département Recherche Fondamentale, Centre ďÉtudes Nucléaires, GrenobleCorrespondence to M. Chabre, Laboratoire de Biophysique Moléculaire et Cellulaire. CENG Boîte Postale 85X, F-38041 Grenoble, FranceSearch for more papers by this authorPhilippe DETERRE, Philippe DETERRE Laboratoire de Biophysique Moléculaire et Cellulaire (Unité Associée 520 au CNRS), Département Recherche Fondamentale, Centre ďÉtudes Nucléaires, GrenobleSearch for more papers by this author First published: February 1989 https://doi.org/10.1111/j.1432-1033.1989.tb14549.xCitations: 273 This review is dedicated to the memory of our friend hermann kühn, a poineer of the biochemistry of visual transduction AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations ROS rod outer segment R* photoexcited rhodopsin T2GDP T2GTP, T2empty, α-subunit of transducin bearing a GDP, a GTP, or with an empty site T Tγ, β and γ subunit of transducin PDE cGMP-specific phosphodiesterase PDEαβ catalytic subunits of PDE I inhibitory subunit of PDE GDP[βS] guanosine 5′-[β-thio]diphosphate GTP[γS] guanosine 5′-[γ-thio]triphosphate GuoPP[NH]P guanosine 5′-[β,γ-imino]triphosphate Enzymes cGMP-specific phosphodiesterase (EC 3.1.4.35) guanylate cyclase (EC 4.6.1.2) REFERENCES 1a. Stryer, L. (1986) Annu. Rev. Neurosci. 9, 87– 119. CrossrefCASPubMedWeb of Science®Google Scholar 1b. Nathans, J. (1987) Annu. Rev. Neurosci. 10, 163– 194. CrossrefCASPubMedWeb of Science®Google Scholar 2 Applebury, M. L. & Hargrave, P. A. (1986) Vision Res. 26, 1881– 1895. CrossrefCASPubMedWeb of Science®Google Scholar 3a. Pugh, E. N. (1987) Annu. Rev. Physiol. 49, 715– 742. CrossrefCASPubMedWeb of Science®Google Scholar 3b. Liebman, P. A., Parker, K. R. & Dratz, E. A. (1987) Annu. Rev. Physiol. 49, 765– 792. CrossrefCASPubMedWeb of Science®Google Scholar 3c. Hurley, J. B. (1987) Annu. Rev. Physiol. 49, 793– 812. CrossrefCASPubMedWeb of Science®Google Scholar 4 Hagins, W. A. (1972) Annu. Rev. Biophys. Bioeng. 1, 131– 158. CrossrefCASPubMedWeb of Science®Google Scholar 5 Kühn, H. (1978) Biochemistry 17, 4389– 4395. CrossrefPubMedWeb of Science®Google Scholar 6 Kühn, H. (1980) Nature (Lond.) 283, 587– 589. CrossrefCASPubMedWeb of Science®Google Scholar 7 Kühn, H. (1984) in Progress in retinal research ( N. Osborne & J. Chader, eds) pp. 123– 153, Pergamon, New York . Google Scholar 8 Fung, B. K. K., Hurley, J. B. & Stryer, L. (1981) Proc. Natl Acad. Sci. USA 78, 152– 156. CrossrefCASPubMedWeb of Science®Google Scholar 9 Yee, R. & Liebman, P. A. (1978) J. Biol. Chem. 253, 8902– 8909. CASPubMedWeb of Science®Google Scholar 10 Fesenko, E. E., Kolesnikov, S. S. & Lyubrsky, A. L. (1985) Nature (Lond.) 313, 310– 313. CrossrefCASPubMedWeb of Science®Google Scholar 11 Cook, J. N., Hanke, W. & Kaupp, U. B. (1987) Proc. Natl Acad. Sci. USA 84, 585– 589. CrossrefCASPubMedWeb of Science®Google Scholar 12 Fleischman, D. & Denisevich, M. (1979) Biochemistry 18, 5060– 5066. CrossrefCASPubMedWeb of Science®Google Scholar 13 Lolley, R. N. & Racz, E. (1982) Vision Res. 22, 1481– 1486. CrossrefCASPubMedWeb of Science®Google Scholar 14 Koch, K. W. & Stryer, L. (1988) Nature (Lond.) 334, 64– 66. CrossrefCASPubMedWeb of Science®Google Scholar 15 Yau, K. W. & Nakatani, K. (1985) Nature (Lond.) 313, 579– 581. CrossrefCASPubMedWeb of Science®Google Scholar 16 Pugh, E. & Altman, J. (1988) Nature (Lond.) 313, 16– 17. CrossrefWeb of Science®Google Scholar 17 Stryer, L. & Bourne, H. R. (1986) Annu. Rev. Cell Biol. 2, 391– 419. CrossrefCASPubMedWeb of Science®Google Scholar 18 Dohlman, H. G., Caron, M. G. & Lefkowitz, R. J. (1987 Biochemistry 26, 2657– 2664. CrossrefCASPubMedWeb of Science®Google Scholar 19 Pfister, C., Chabre, M., Plouet, J., Tuyen, V. V., De Kozak, Y., Faure, J. P. & Kühn, H. (1985) Science (Wash. DC) 228, 891– 893. CrossrefCASPubMedWeb of Science®Google Scholar 20 Chabre, M. (1985) Annu. Rev. Biophys. Chem. 14, 331– 360. CASPubMedWeb of Science®Google Scholar 21 Ovchinnikov, Y. A. (1982) FEBS Lett. 148, 179– 181. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 22 Hargrave, P. A., McDowell, J. H., Curtis, D. R., Wang, J., Juszezak, E., Fong, S.-L., Rao, J. K. M. & Argos, P. (1983) Biophys. Struct. Mechanism 9, 235– 244. CrossrefCASPubMedWeb of Science®Google Scholar 23 Martin, R. L., Wood, C., Baehr, W. & Applebury, M. L. (1986) Science (Wash. DC) 232, 1266– 1269. CrossrefCASPubMedWeb of Science®Google Scholar 24 Cooper, A. (1979) Nature (Lond.) 282, 531– 533. CrossrefPubMedWeb of Science®Google Scholar 25 Nathans, J., Thomas, D. & Hogness, D. S. (1986) Science (Wash. DC) 232, 193– 202. CrossrefCASPubMedWeb of Science®Google Scholar 26 Dixon, R. A. F., Sigal, I. S., Rands, E., Register, R. B., Candelare, M. R., Blake, A. D. & Strader, C. D. (1987) Nature (Lond.) 326, 73– 77. CrossrefCASPubMedWeb of Science®Google Scholar 27 Honig, B., Dinur, U., Nakanishi, K., Balogh-Nair, V., Gavinowicz, M. A., Arnaboldi, M. & Motto, M. G. (1979) J. Am. Chem. Soc. 101, 7084– 7086. CrossrefCASWeb of Science®Google Scholar 28 Katikani, H., Katikani, T., Rodman, H. & Honig, B. (1985) Photochem. Photobiol. 41, 471– 479. Wiley Online LibraryPubMedWeb of Science®Google Scholar 29 Chabre, M. & Breton, J. (1979) Photochem. Photobiol. 30, 295– 299. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 30 Chabre, M. & Cavaggioni, A. (1975) Biochim. Biophys. Acta 382, 336– 343. CrossrefCASPubMedWeb of Science®Google Scholar 31 Vuong, T. M., Pfister, C., Worcester, D. L. & Chabre, M. (1987) Biophys. J. 52, 587– 594. CrossrefCASPubMedWeb of Science®Google Scholar 32 Kühn, H. & Dreyer, W. J. (1972) FEBS Lett. 20, 1– 6. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 33 Bownds, D., Dawes, J., Miller, J. & Stahlman, M. (1972) Nature (Lond.) 237, 125– 127. CrossrefCASPubMedWeb of Science®Google Scholar 34 Kühn, H. & Hargrave, P. A. (1981) Biochemistry 20, 2410– 2417. CrossrefCASPubMedWeb of Science®Google Scholar 35 Kaupp, U. B., Schnetkamp, P. P. M. & Junge, W. (1981) Biochemistry 20, 5511– 5516. CrossrefCASPubMedWeb of Science®Google Scholar 36 Hildebrandt, J. D., Codina, J., Rosenthal, W., Birnbaumer, L., Neer, E. J., Yamazaki, A. & Bitensky, M. W. (1985) J. Biol. Chem. 260, 14867– 14872. CASPubMedWeb of Science®Google Scholar 37 Hurley, J. B., Fong, H. K. W., Teplon, D. B., Dreyer, W. J. & Simon, M. I. (1984) Proc. Natl Acad. Sci. USA 81, 6948– 6952. CrossrefCASPubMedWeb of Science®Google Scholar 38 Buss, J. E., Mumby, S. M., Casey, P. J., Gilman, A. G. & Sefton, B. M. (1987) Proc. Natl Acad. Sci. USA 84, 7493– 7497. CrossrefCASPubMedWeb of Science®Google Scholar 39 Bruckert, F., Vuong, T. M. & Chabre, M. (1988) Eur. J. Biophys. 16, 207– 218. CrossrefCASPubMedWeb of Science®Google Scholar 40 Baehr, W., Morita, E. A., Swanson, R. J. & Applebury, M. L. (1982) J. Biol. Chem. 257, 6452– 6460. CASPubMedWeb of Science®Google Scholar 41 Saibil, H. (1982) J. Mol. Biol. 158, 435– 456. CrossrefCASPubMedWeb of Science®Google Scholar 42 Yamanaka, G., Eckstein, F. & Stryer, L. (1985) Biochemistry 24, 8094– 8101. CrossrefCASPubMedWeb of Science®Google Scholar 43 Deterre, P., Bigay, J., Pfister, C. & Chabre, M. (1984) FEBS Lett. 178, 228– 232. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 44 Bennett, N. & Dupont, Y. (1985) J. Biol. Chem. 260, 4156– 4168. CASPubMedWeb of Science®Google Scholar 45 Wilden, U., Hall, S. W. & Kühn, H. (1986) Proc. Natl Acad. Sci. USA 83, 1174– 1178. CrossrefCASPubMedWeb of Science®Google Scholar 46 Kühn, H., Bennett, N., Michel-Villaz, M. & Chabre, M. (1981) Proc. Natl Acad. Sci. USA 18, 6873– 6877. CrossrefWeb of Science®Google Scholar 47 Hofmann, K. P., Uhl, R., Hoffmann, W. & Krentz, W. (1976) Biophys. Struct. Mechanism 2, 61– 77. CrossrefCASPubMedWeb of Science®Google Scholar 48 Vuong, T. M., Chabre, M. & Stryer, L. (1984) Nature (Lond.) 311, 659– 661. CrossrefCASPubMedWeb of Science®Google Scholar 49 Fung, B. K. K. (1983) J. Biol. Chem. 258, 10495– 10502. CASPubMedWeb of Science®Google Scholar 50 Emeis, D., Kühn, H., Reichert, J. & Hofmann, K. P. (1982) FEBS Lett. 143, 29– 34. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 51 Bennett, N., Michel-Villaz, M. & Kühn, H. (1982) Eur. J. Biochem. 127, 97– 103. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 52 Pfister, C., Kühn, H. & Chabre, M. (1983) Eur. J. Biochem. 136, 489– 499. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 53 Kühn, H. (1981) Curr. Top. Membr. Transp. 15, 171– 201. CrossrefCASWeb of Science®Google Scholar 54 Phillips, E. S. & Cone, R. A. (1986) Biophys. J. 49, 277a. Google Scholar 55 Fung, B. K. K. & Nash, C. R. (1983) J. Biol. Chem. 258, 10503– 10510. CASPubMedWeb of Science®Google Scholar 56 Sternweis, P. C. & Gilman, A. G. (1982) Proc. Natl Acad. Sci. USA 79, 4888– 4891. CrossrefCASPubMedWeb of Science®Google Scholar 57 Bigay, J., Deterre, P., Pfister, C. & Chabre, M. (1985) FEBS Lett. 191, 181– 185. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 58 Bigay, J., Deterre, P., Pfister, C. & Chabre, M. (1987) EMBO J. 6, 2907– 2913. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 59 Carlier, M. F., Didry, D., Melki, R., Chabre, M. & Pantaloni, D. (1988) Biochemistry 27, 3555– 3559. CrossrefCASPubMedWeb of Science®Google Scholar 60 Lunardi, J., Dupuis, A., Garin, J., Issartel, J. P., Michel, L., Chabre, M. & Vignais, P. V. (1988) Proc. Natl Acad. Sci. USA 85, 9858– 9862. CrossrefWeb of Science®Google Scholar 61 Miki, N., Baraban, J. M., Keirns, J. J., Boyce, J. J. & Bitensky, M. W. (1975) J. Biol. Chem. 250, 6320– 6327. CASPubMedWeb of Science®Google Scholar 62 Hurley, J. B. & Stryer, L. (1982) J. Biol. Chem. 257, 11094– 11099. CASPubMedWeb of Science®Google Scholar 63 Deterre, P., Bigay, J., Robert, M., Kühn, H. & Chabre, M. (1986) Proteins Struct. Funct. Genet. 1, 188– 193. Wiley Online LibraryCASPubMedGoogle Scholar 64 Deterre, P., Bigay, J., Forquet, F., Robert, M. & Chabre, M. (1988) Proc. Natl Acad. Sci. USA 85, 2424– 2428. CrossrefCASPubMedWeb of Science®Google Scholar 65 Wensel, T. G. & Stryer, L. (1986) Proteins Struct. Funct. Genet. 1, 90– 99. Wiley Online LibraryCASPubMedGoogle Scholar 66 Detwiller, P. B., Conner, J. D., Bodoia, R. D. (1982) Nature (Lond.) 300, 59– 61. CrossrefWeb of Science®Google Scholar 67 Haynes, L. W., Kay, A. R. & Yau, K.-W. (1986) Nature (Lond.) 321, 66– 70. CrossrefCASPubMedWeb of Science®Google Scholar 68 Zimmerman, A. L. & Baylor, D. A. (1986) Nature (Lond.) 321, 70– 72. CrossrefCASPubMedWeb of Science®Google Scholar 69 Caretta, A., Cavaggioni, A. & Sorbi, R. T. (1979) J. Physiol. (Lond.) 295, 171– 178. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 70 Cavaggioni, A. & Sorbi, R. T. (1981) Proc. Natl Acad. Sci. USA 78, 3964– 3968. CrossrefCASPubMedWeb of Science®Google Scholar 71 Koch, K.-W. & Kaupp, U. B. (1985) J. Biol. Chem. 260, 6788– 6800. CASPubMedWeb of Science®Google Scholar 72 Hanke, W., Cook, J. N., Kaupp, U. B. (1988) Proc. Natl Acad. Sci. USA 85, 94– 98. CrossrefCASPubMedWeb of Science®Google Scholar 73 Matesic, D. & Liebman, P. A. (1987) Nature (Lond.) 326, 600– 603. CrossrefCASPubMedWeb of Science®Google Scholar 74 Liebman, P. A. & Pugh, E. N. (1980) Nature (Lond.) 287, 734– 736. CrossrefCASPubMedWeb of Science®Google Scholar 75 Wistow, G., Katial, A., Craft, C. & Shinohara, T. (1986) FEBS Lett. 196, 23– 28. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 76 Yamaki, K., Takahashi, Y., Sakuragi, S. & Matsubara, K. (1987) Biochem. Biophys. Res. Commun. 142, 904– 910. CrossrefCASPubMedWeb of Science®Google Scholar 77 Shinohara, T., Dietzschold, B., Craft, C. M., Wistow, G., Early, J. J., Donoso, L. A., Horwitz, J. & Tao, R. (1987) Proc. Natl Acad. Sci. USA 84, 6975– 6979. CrossrefCASPubMedWeb of Science®Google Scholar 78 Sibley, D. R., Benovic, J. L., Caron, M. G. & Lefkowitz, R. J. (1987) Cell 48, 913– 922. CrossrefCASPubMedWeb of Science®Google Scholar 79 Benovic, J. L., Kühn, H., Weyand, I., Codina, J., Caron, M. G. & Lefkowitz, R. J. (1987) Proc. Natl Acad. Sci. USA 84, 8879– 8882. CrossrefCASPubMedWeb of Science®Google Scholar 80 Dratz, E. A., Lewis, J. W., Schaechter, L. E., Parker, K. R. & Kliger, D. S. (1987) Biochem. Biophys. Res. Commun. 146, 379– 386. CrossrefCASPubMedWeb of Science®Google Scholar 81 Wagner, R., Ryba, N. & Uhl, R. (1988) FEBS Lett. 234, 44– 48. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 82 Korn, E. D., Carlier, M. F. & Pantaloni, D. (1987) Science (Wash. DC) 238, 638– 644. CrossrefCASPubMedWeb of Science®Google Scholar 83 Arshavsky, V. Y., Antoch, M. P. & Philippov, P. P. (1987) FEBS Lett. 224, 19– 22. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 84 Chabre, M., Bigay, J., Bruckert, F., Bornancin, F., Deterre, P., Pfister, C. & Vuong, T. M. (1988) Cold Spring Harbor Symp. Quant. Biol. 53. CrossrefCASGoogle Scholar 85 Ovchinnikov, Y. U., Lipkin, V. M., Kumarev, V. P., Gubanov, V. V., Khramtsov, N. V., Akhmedov, N. B., Zagranichny, V. E. & Muradov, K. G. (1986) FEBS Lett. 204, 288– 292. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 86 Ovchinnikov, Y. U., Gubanov, V. V., Khramtsov, N. V., Ischenko, K. A., Zagranichny, V. E., Muradov, K. G., Shuvaeva, T. M. & Lipkin, V. M. (1987) FEBS Lett. 223, 169– 173. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 87 Ovchinnikov, Y. A., Abdulaev, N. G. & Bogachuk, A. S. (1988) FEBS Lett. 230, 1– 5. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 88 Sitaramayya, A., Casadevall, C., Bennett, N. & Hakki, S. I. (1988) Biochemistry 27, 4880– 4887. CrossrefCASPubMedWeb of Science®Google Scholar Citing Literature Volume179, Issue2February 1989Pages 255-266 ReferencesRelatedInformation